Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
- Products
-
- chlorproMAZINE Hydrochloride Tablets
- Where it was sold
-
USA Nationwide
Nationwide
- About this recall
- chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-862-01